The manufacturer is no longer supplying all strengths of Subutex (buprenorphine) and Suboxone (buprenorphine and naloxone) sublingual tablets in the UK. Alternative branded and generic buprenorphine sublingual tablets remain available.
These tablets were discontinued on 5 Jan 2026. Various strengths of short-dated buprenorphine/naloxone (Zubsolv®) sublingual tablets are available but future UK supply is to be confirmed. Branded and generic buprenorphine sublingual tablets and oral lyophilisate remain available.
There will be limited supply from early February to early June 2026. Paracetamol 500mg tablets and codeine 30mg tablets remain available and can support a full uplift in demand. Other strengths and forms of co-codamol remain available but cannot support an uplift in demand.
Fresenius Kabi are transitioning their Steriflex® range of licensed and unlicensed IV fluid bags to DEHP-free IV fluid bags and have experienced a shortage during this change due to increased demands and lack of availability of raw materials. This alert outlines management plan.